Search

everythinglearnresearchcommunity

for

Search:↓

High-quality data on skin cancer is crucial for understanding its trends and allocating healthcare resources effectively.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Provenge extends prostate cancer survival by about 4 months.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

The investigation found no work-related causes for employee hair loss at Equifax Payment Services, and the environment was not hazardous.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Better awareness of chemotherapy's side effects improves self-care.

Finasteride use varies among Denmark, Finland, Norway, and Sweden, with higher usage in Finland and Sweden.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Finasteride use may increase the risk of male breast cancer.

Women with alopecia may have a higher chance of getting thyroid cancer.

Higher cholesterol levels increase aggressive prostate cancer risk.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.